NuWave Investment Management’s DexCom DXCM Stock Holding History

NuWave Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-5,443	Closed	-$406K	–	307
2022 Q2	$406K	Buy	+5,443	New	+$497K	0.54%	66
2022 Q1	–	Sell	-7,120	Closed	-$956K	–	304
2021 Q4	$956K	Buy	+7,120	New	+$1.02M	1.08%	14
2021 Q2	–	Sell	-232	Closed	-$21K	–	353
2021 Q1	$21K	Sell	232 -32	-12%	-$3K	0.03%	259
2020 Q4	$24K	Sell	264 -1,656	-86%	-$148K	0.03%	280
2020 Q3	$198K	Sell	1,920 -13,728	-88%	-$1.43M	0.3%	107
2020 Q2	$1.47M	Buy	+15,648	New	+$1.4M	1.94%	8

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NuWave Investment Management's DXCM Position: Q3 2022 in Review

NuWave Investment Management sold out of DexCom (DXCM) in Q3 2022, closing a stake of 5,443 shares — an estimated $406K sold.

NuWave Investment Management first reported a position in DXCM in Q2 2020 and held it in 6 quarters. The position peaked at $1.47M in Q2 2020. 795 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

NuWave Investment Management reported no remaining DexCom position as of Q3 2022 after selling out during the quarter.
NuWave Investment Management sold 5,443 DexCom shares in Q3 2022, an estimated $406K.
NuWave Investment Management first reported a position in DexCom in Q2 2020 and held it in 6 quarters.
NuWave Investment Management's DexCom position peaked at $1.47M in Q2 2020.
795 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on NuWave Investment Management's 13F filing for Q3 2022, filed 21 Oct 2022.